This compound is a modified analog of luteinizing hormone-releasing hormone (LHRH), in which the sixth amino acid position features a D-lysine residue. It is an active pharmaceutical ingredient used in research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 52671-12-2
Triptorelin
pharmaceutical raw material
Triptorelin acetate
pharmaceutical raw material
Nafarelin
pharmaceutical raw material
10-Gly-LHRH
pharmaceutical raw material
Gonadorelin monoacetate hydrate
pharmaceutical raw material
Ibuprofen sodium dihydrate
pharmaceutical raw material
Apr-246
pharmaceutical raw material
Prednisone
pharmaceutical raw material
N-[1-[[1-[[(2S)-1-[[(2S)-1-[[(2R)-6-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
HOWBSMILMYIFKQ-CTGKPQBXSA-N
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6